Background and aims There are increasing case reports of rhino-orbital mucormycosis in
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus�…

Background and aims No drugs are currently approved for Coronavirus Disease-2019
(COVID-19), although some have been tried. In view of recent studies and discussion on�…

Aim To estimate the prevalence of both cardiometabolic and other co‐morbidities in patients
with COVID‐19, and to estimate the increased risk of severity of disease and mortality in�…

Background Anemia, a common complication of chronic kidney disease, usually develops
as a consequence of erythropoietin deficiency. Recombinant human erythropoietin (epoetin�…

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a leading cause of cancer-
related mortality worldwide. Several studies have shown that statins could have�…

PURPOSE: To determine trends in incidence, treatment, and survival with primary uveal
melanoma in the United States over a 36-year period from 1973 to 2008. DESIGN�…

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC�…

The field of biomaterials has become a vital area, as these materials can enhance the
quality and longevity of human life and the science and technology associated with this field�…

Background Understanding the epidemiology and clinical course of multisystem
inflammatory syndrome in children (MIS-C) and its temporal association with coronavirus�…

Background Resistance to therapy with BRAF kinase inhibitors is associated with
reactivation of the mitogen-activated protein kinase (MAPK) pathway. To address this�…